ENSC

SEC source: 0001192482-21-000618 · edgar.xml · derivative · entry 4

Kirkpatrick Lynn · CIK 0001418785 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,400

Underlying: Common Stock · 263,400 shares

Expires 2026-01-15

F2 · price: Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0001192482-21-000618 · edgar.xml · derivative · entry 3

Kirkpatrick Lynn · CIK 0001418785 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,994

Underlying: Common Stock · 9,994 shares

Expires 2022-12-21

F2 · price: Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0001192482-21-000618 · edgar.xml · derivative · entry 2

Kirkpatrick Lynn · CIK 0001418785 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,950

Underlying: Common Stock · 99,950 shares

Expires 2022-12-01

F2 · price: Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0001192482-21-000618 · edgar.xml · nonDerivative · entry 1

Kirkpatrick Lynn · CIK 0001418785 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,851

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Ensysce common stock was automatically converted into the right to receive a pro rata portion of 17,334,518 shares of the Issuer's common stock.

SEC source: 0001192482-21-000613 · edgar.xml · derivative · entry 1

Schmidt William K · CIK 0001301122 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,142

Underlying: Common Stock · 69,142 shares

Expires 2026-02-04

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F1 · derivative.exercise_date: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0001192482-21-000615 · edgar.xml · derivative · entry 1

Martin Steven Robert · CIK 0001328822 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,850

Underlying: Common Stock · 65,850 shares

Expires 2030-08-09

F2 · security: The option vests over three years with 1/3 of the total number of shares subject to the option vesting on the first anniversary of the date of grant and 1/36th of the total number of shares subject to the option vesting monthly thereafter, until fully vested on 08/10/2023.

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F1 · derivative.exercise_date: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0001493152-21-016122 · ownership.xml · nonDerivative · entry 2

Chang William H · CIK 0001594408 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 2,242,189

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Ensysce common stock was automatically converted into the right to receive a pro rata portion of 17,334,518 shares of the Issuer's common stock.

F3 · ownership.nature: Represents the shares held by the trusts in which the Reporting Person has sole or shared voting and dispositive power.

SEC source: 0001493152-21-016122 · ownership.xml · nonDerivative · entry 1

Chang William H · CIK 0001594408 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,451

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Ensysce common stock was automatically converted into the right to receive a pro rata portion of 17,334,518 shares of the Issuer's common stock.

F2 · ownership.direct: Represents the shares owned jointly with the Reporting Person's wife.

SEC source: 0001192482-21-000616 · edgar.xml · derivative · entry 1

Benton Andrew · CIK 0001867975 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,850

Underlying: Common Stock · 65,850 shares

Expires 2030-01-23

F2 · security: The option vests over three years with 1/3 of the total number of shares subject to the option vesting on the first anniversary of the date of grant and 1/36th of the total number of shares subject to the option vesting monthly thereafter, until fully vested on 01/24/2023.

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F1 · derivative.exercise_date: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0001192482-21-000612 · edgar.xml · derivative · entry 2

Birkett Kevin Geoffrey · CIK 0001867942 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,250

Underlying: Common Stock · 329,250 shares

Expires 2029-02-28

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F1 · derivative.exercise_date: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0001192482-21-000612 · edgar.xml · derivative · entry 1

Birkett Kevin Geoffrey · CIK 0001867942 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,755

Underlying: Common Stock · 19,755 shares

Expires 2028-10-01

F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

F1 · derivative.exercise_date: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.

SEC source: 0000925421-20-000259 · edgar.xml · nonDerivative · entry 1

MORGAN STANLEY · CIK 0000895421 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Subsidiary

Disclosed balance after: 0

F1 · security: Pursuant to the Issuer's Extension Amendment and the Trust Amendment proposals set forth in the Issuer's Proxy Statement filed with the Commission on June 2, 2020, the Issuer's public stockholders were offered the opportunity to redeem their shares in exchange for their pro rata portion of the funds available in the trust account at the time of the Special Meeting on June 23, 2020, which elections became irrevocable on June 19, 2020. Morgan Stanley elected to redeem its shares and will receive its per-share pro rata portion of the trust account, estimated by the Issuer to be approximately $10.44.

F1 · price: Pursuant to the Issuer's Extension Amendment and the Trust Amendment proposals set forth in the Issuer's Proxy Statement filed with the Commission on June 2, 2020, the Issuer's public stockholders were offered the opportunity to redeem their shares in exchange for their pro rata portion of the funds available in the trust account at the time of the Special Meeting on June 23, 2020, which elections became irrevocable on June 19, 2020. Morgan Stanley elected to redeem its shares and will receive its per-share pro rata portion of the trust account, estimated by the Issuer to be approximately $10.44.

SEC source: 0001615774-18-000388 · s108741_form4.xml · nonDerivative · entry 2

WEIL A LORNE · CIK 0000921873 · Director · Executive Chairman

Hydra LAC, LLC · CIK 0001723195 · Sponsor Affiliate of the Co.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 867,842

F2 · shares: As contemplated by the securities subscription agreement between such reporting person and the Company, 132,158 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F2 · price: As contemplated by the securities subscription agreement between such reporting person and the Company, 132,158 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F3 · ownership.nature: Represents shares of common stock held by the Sponsor Affiliate. The shares held by the Sponsor Affiliate are beneficially owned by A. Lorne Weil, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate. Mr. Weil owns all of the membership interests in the Sponsor Affiliate. Mr. Weil disclaims beneficial ownership over any securities owned by the Sponsor Affiliate in which he does not have any pecuniary interest.

SEC source: 0001615774-18-000388 · s108741_form4.xml · nonDerivative · entry 1

WEIL A LORNE · CIK 0000921873 · Director · Executive Chairman

Hydra LAC, LLC · CIK 0001723195 · Sponsor Affiliate of the Co.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,900

F1 · shares: As contemplated by the securities subscription agreement between such reporting person and the Company, 40,645 shares held by Mr. Weil were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F1 · price: As contemplated by the securities subscription agreement between such reporting person and the Company, 40,645 shares held by Mr. Weil were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

SEC source: 0001615774-18-000384 · s108739_form4.xml · nonDerivative · entry 1

Carrera Eric · CIK 0001657726 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,701

F1 · shares: As contemplated by the securities subscription agreement between the reporting person and the Company, 8,330 shares held by Mr. Carrera were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F1 · price: As contemplated by the securities subscription agreement between the reporting person and the Company, 8,330 shares held by Mr. Carrera were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

SEC source: 0001615774-18-000382 · s108737_form4.xml · nonDerivative · entry 1

Silvers Daniel B. · CIK 0001468195 · Director · Chief Executive Officer

Matthews Lane Capital Partners LLC · CIK 0001722952 · Sponsors of the Co.

MLCP GLL Funding LLC · CIK 0001722935 · Sponsor Affiliate of the Co.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,128,370

F1 · shares: As contemplated by the securities subscription agreement between each reporting person and the Company, 171,832 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the "Sponsor"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F1 · price: As contemplated by the securities subscription agreement between each reporting person and the Company, 171,832 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the "Sponsor"), were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F2 · balance_after: Represents 887,127 shares of common stock held by the Sponsor Affiliate. Represents 241,243 shares of common stock held by the Sponsor. The shares held by the Sponsor Affiliate and the Sponsor are beneficially owned by Daniel B. Silvers, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate and the Sponsor. Mr. Silvers owns all of the membership interests in the Sponsor Affiliate and the Sponsor. Mr. Silvers disclaims beneficial ownership over any securities owned by the Sponsor and the Sponsor Affiliate in which he does not have any pecuniary interest.

F2 · ownership.nature: Represents 887,127 shares of common stock held by the Sponsor Affiliate. Represents 241,243 shares of common stock held by the Sponsor. The shares held by the Sponsor Affiliate and the Sponsor are beneficially owned by Daniel B. Silvers, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate and the Sponsor. Mr. Silvers owns all of the membership interests in the Sponsor Affiliate and the Sponsor. Mr. Silvers disclaims beneficial ownership over any securities owned by the Sponsor and the Sponsor Affiliate in which he does not have any pecuniary interest.

SEC source: 0001615774-18-000390 · s108738_form4.xml · nonDerivative · entry 2

HG Vora Capital Management, LLC · CIK 0001525362 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,462,500

F2 · shares: As contemplated by the securities subscription agreement between HG Vora Special Opportunities and the Company, 375,000 shares held by HG Vora Special Opportunities were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F2 · price: As contemplated by the securities subscription agreement between HG Vora Special Opportunities and the Company, 375,000 shares held by HG Vora Special Opportunities were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F1 · ownership.nature: Securities owned directly by HG Vora Special Opportunities Master Fund, Ltd. ("HG Vora Special Opportunities"). HG Vora Capital Management, LLC ("HG Vora Capital) is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as an investment adviser to certain investment entities. HG Vora Capital, as investment manager of HG Vora Special Opportunities, may be deemed to beneficially own the securities owned directly by HG Vora Special Opportunities.

SEC source: 0001615774-18-000386 · s108740_form4.xml · nonDerivative · entry 1

Peng George · CIK 0001651293 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,014

F1 · shares: As contemplated by the securities subscription agreement between the reporting person and the Company, 13,251 shares held by Mr. Peng were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

F1 · price: As contemplated by the securities subscription agreement between the reporting person and the Company, 13,251 shares held by Mr. Peng were forfeited since the underwriters did not exercise their overallotment option in the Company's initial public offering.

SEC source: 0001144204-17-062471 · tv480821_4.xml · nonDerivative · entry 2

WEIL A LORNE · CIK 0000921873 · Director · Executive Chairman

Hydra LAC, LLC · CIK 0001723195 · Sponsor Affiliate of the Co.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,000,000

F3 · shares: As contemplated by the securities subscription agreement between such reporting person and the Company, 169,517 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate"), were forfeited upon consummation of the Company's initial public offering for no consideration.

F3 · price: As contemplated by the securities subscription agreement between such reporting person and the Company, 169,517 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate"), were forfeited upon consummation of the Company's initial public offering for no consideration.

F4 · balance_after: Includes an aggregate of 132,159 shares held by the Sponsor Affiliate that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not exercised.

F5 · ownership.nature: Represents shares of common stock held by the Sponsor Affiliate. The shares held by the Sponsor Affiliate are beneficially owned by A. Lorne Weil, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate. Mr. Weil owns all of the membership interests in the Sponsor Affiliate. Mr. Weil disclaims beneficial ownership over any securities owned by the Sponsor Affiliate in which he does not have any pecuniary interest.

SEC source: 0001144204-17-062471 · tv480821_4.xml · nonDerivative · entry 1

WEIL A LORNE · CIK 0000921873 · Director · Executive Chairman

Hydra LAC, LLC · CIK 0001723195 · Sponsor Affiliate of the Co.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,545

F1 · shares: As contemplated by the securities subscription agreement between such reporting person and the Company, 187,166 shares held by Mr. Weil were forfeited upon consummation of the Company's initial public offering for no consideration.

F1 · price: As contemplated by the securities subscription agreement between such reporting person and the Company, 187,166 shares held by Mr. Weil were forfeited upon consummation of the Company's initial public offering for no consideration.

F2 · balance_after: Includes an aggregate of 40,645 shares held by Mr. Weil that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not exercised.

SEC source: 0001144204-17-062469 · tv480819_4.xml · nonDerivative · entry 1

Carrera Eric · CIK 0001657726 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,031

F1 · shares: As contemplated by the securities subscription agreement between the reporting person and the Company, 1,465 shares held by Mr. Carrera were forfeited upon consummation of the Company's initial public offering for no consideration.

F1 · price: As contemplated by the securities subscription agreement between the reporting person and the Company, 1,465 shares held by Mr. Carrera were forfeited upon consummation of the Company's initial public offering for no consideration.

F2 · balance_after: Includes an aggregate of 8,330 shares held by Mr. Carrera that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not fully exercised.

SEC source: 0001144204-17-062472 · tv480824_4.xml · nonDerivative · entry 1

Silvers Daniel B. · CIK 0001468195 · Director · Chief Executive Officer

Matthews Lane Capital Partners LLC · CIK 0001722952 · Sponsor of the Company

MLCP GLL Funding LLC · CIK 0001722935 · Sponsor Affiliate of the Co.

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,300,202

F1 · shares: As contemplated by the securities subscription agreement between each reporting person and the Company, 359,869 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the "Sponsor"), were forfeited upon consummation of the Company's initial public offering for no consideration.

F1 · price: As contemplated by the securities subscription agreement between each reporting person and the Company, 359,869 shares held by MLCP GLL Funding LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate") and Matthews Lane Capital Partners LLC, a sponsor of the Company (the "Sponsor"), were forfeited upon consummation of the Company's initial public offering for no consideration.

F2 · balance_after: Includes an aggregate of 171,833 shares held by the Sponsor Affiliate and the Sponsor that are subject to forfeiture to the extent that the underwriters' overallotment in the Company's initial public offering is not fully exercised.

F3 · ownership.nature: Represents 1,022,222 shares of common stock held by the Sponsor Affiliate. Represents 277,980 shares of common stock held by the Sponsor. The shares held by the Sponsor Affiliate and the Sponsor are beneficially owned by Daniel B. Silvers, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate and the Sponsor. Mr. Silvers owns all of the membership interests in the Sponsor Affiliate and the Sponsor. Mr. Silvers disclaims beneficial ownership over any securities owned by the Sponsor and the Sponsor Affiliate in which he does not have any pecuniary interest.

SEC source: 0001144204-17-062470 · tv480820_4.xml · nonDerivative · entry 1

HG Vora Capital Management, LLC · CIK 0001525362 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,837,500

F1 · shares: As contemplated by the securities subscription agreement between HG Vora Special Opportunities Master Fund, Ltd. ("HG Vora Special Opportunities") and the Company, 718,750 shares held by HG Vora Special Opportunities were forfeited upon consummation of the Company's initial public offering for no consideration.

F1 · price: As contemplated by the securities subscription agreement between HG Vora Special Opportunities Master Fund, Ltd. ("HG Vora Special Opportunities") and the Company, 718,750 shares held by HG Vora Special Opportunities were forfeited upon consummation of the Company's initial public offering for no consideration.

F2 · balance_after: Includes 375,000 shares beneficially owned by HG Vora Capital Management, LLC ("HG Vora Capital") that are subject to forfeiture to the extent the underwriters' overallotment option in the Company's initial public offering is not fully exercised.

F3 · ownership.nature: Securities owned directly by HG Vora Special Opportunities. HG Vora Capital is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as an investment adviser to certain investment entities. HG Vora Capital, as investment manager of HG Vora Special Opportunities, may be deemed to beneficially own the securities owned directly by HG Vora Special Opportunities.

SEC source: 0001144204-17-062468 · tv480818_4.xml · nonDerivative · entry 1

Peng George · CIK 0001651293 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,265

F1 · shares: As contemplated by the securities subscription agreement between the reporting person and the Company, 733 shares held by Mr. Peng were forfeited upon consummation of the Company's initial public offering for no consideration.

F1 · price: As contemplated by the securities subscription agreement between the reporting person and the Company, 733 shares held by Mr. Peng were forfeited upon consummation of the Company's initial public offering for no consideration.

F2 · balance_after: Includes an aggregate of 13,251 shares held by Mr. Peng that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not fully exercised.

SEC source: 0001615774-18-000390 · s108738_form4.xml · nonDerivative · entry 1

HG Vora Capital Management, LLC · CIK 0001525362 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,837,500

F1 · ownership.nature: Securities owned directly by HG Vora Special Opportunities Master Fund, Ltd. ("HG Vora Special Opportunities"). HG Vora Capital Management, LLC ("HG Vora Capital) is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as an investment adviser to certain investment entities. HG Vora Capital, as investment manager of HG Vora Special Opportunities, may be deemed to beneficially own the securities owned directly by HG Vora Special Opportunities.